Improved oral bioavalability of mebudipine upon administration in PhytoSolve and Phosal-based formulation (PBF).

about

Determination of Mebudipine in Human Plasma by Liquid Chromatography-tandem Mass Spectrometry Design and evaluation of oral nanoemulsion drug delivery system of mebudipine.

P2860

Q41808342-98C97F5A-8728-4853-AF54-5BE1A3F379B4 Q53332700-DC8FB76A-27C6-4160-8244-63049817F2DC

P2860

Improved oral bioavalability of mebudipine upon administration in PhytoSolve and Phosal-based formulation (PBF).

Item

http://www.wikidata.org/entity/Q41904414

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Improved oral bioavalability o ...... hosal-based formulation (PBF).

@en

type

Item

label

Improved oral bioavalability o ...... hosal-based formulation (PBF).

@en

prefLabel

Improved oral bioavalability o ...... hosal-based formulation (PBF).

@en

P1476

Improved oral bioavalability o ...... Phosal-based formulation (PBF)

@en

P2093

Fariborz Keyhanfar

http://www.w3.org/2001/XMLSchema#string

P2860

Oral lipid-based formulations.

Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update.

Phospholipids and lipid-based formulations in oral drug delivery.

Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine.

Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe.

High performance liquid chromatography of mebudipine: application to pharmacokinetic study.

Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: in vitro evaluation and bioavailability studies in rabbits.

The effect of mebudipine and dibudipine, two new Ca2+ channel blockers, in comparison with nifedipine on Ca2+ spikes of F1 neuronal soma membrane in Helix aspersa.

Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-beta-cyclodextrin.

Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats.

P2888

s12249-013-0039-x

P304

96-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12249-013-0039-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Samira Khani

P577

2013-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010514781

http://www.w3.org/2001/XMLSchema#string

P698

24151144

http://www.w3.org/2001/XMLSchema#string

P932

3909151

http://www.w3.org/2001/XMLSchema#string

Improved oral bioavalability of mebudipine upon administration in PhytoSolve and Phosal-based formulation (PBF).

about

P2860

P2860

Improved oral bioavalability of mebudipine upon administration in PhytoSolve and Phosal-based formulation (PBF).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932